Hjem › Interstitielle lungesykdommer › Kansas
Kliniske studier for Interstitielle lungesykdommer i Kansas
13 studier for Interstitielle lungesykdommer søker deltakere på steder i Kansas.
Byer i Kansas
Offisiell studietekst (engelsk)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA002, Kansas City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07179380A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kansas City
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Kansas Medical Center, Kansas City
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Kansas School of Medicine, Kansas City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Kansas Medical Center, Kansas City
RekruttererFase 2/3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06328777A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05943535Interstitial Lung Disease Research Unit Biobank
- The University of Kansas Medical Center, Kansas City
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT05392881Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 3 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT04624490Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Kansas, Kansas City
RekruttererObservasjonsstudie
Alder 18 til 90 · Alle kjønn · Oppdatert 3. mai 2024 · NCT06397677Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.